Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[2]  M. Folstein,et al.  Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. , 1995, Archives of neurology.

[3]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  T. Lehtimäki,et al.  Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. , 1999, Clinical chemistry.

[5]  Hiroshi Takahashi,et al.  Developmental changes in distribution of death‐associated protein kinase mRNAs , 1999, Journal of neuroscience research.

[6]  J. Ávila,et al.  Evidence for the role of MAP1B in axon formation. , 2001, Molecular biology of the cell.

[7]  R. Strausberg,et al.  High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A. Kimchi,et al.  Death-associated Protein (DAP) Kinase Plays a Central Role in Ceramide-induced Apoptosis in Cultured Hippocampal Neurons* , 2002, The Journal of Biological Chemistry.

[9]  Mutsuya Yamamoto,et al.  DAP kinase activity is critical for C(2)-ceramide-induced apoptosis in PC12 cells. , 2002, European journal of biochemistry.

[10]  Sunit Das,et al.  Ca2+-dependent Phosphorylation of Syntaxin-1A by the Death-associated Protein (DAP) Kinase Regulates Its Interaction with Munc18* , 2003, Journal of Biological Chemistry.

[11]  S. Scheff,et al.  Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies , 2003, Neurobiology of Aging.

[12]  M. Kamboh,et al.  Molecular Genetics of Late‐Onset Alzheimer's Disease , 2004, Annals of human genetics.

[13]  C. Caltagirone,et al.  Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer’s disease , 2004, Journal of Neurology.

[14]  Peter P. Zandi,et al.  Apolipoprotein E ϵ4 Count Affects Age at Onset of Alzheimer Disease,but Not Lifetime Susceptibility: The Cache County Study , 2004 .

[15]  B. Price,et al.  Memory dysfunction in clinical practice. , 2005, Discovery medicine.

[16]  P. Marsh,et al.  Glycogen synthase kinase-3β phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons , 2005, Journal of Cell Science.

[17]  Bianca Habermann,et al.  Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis , 2005, Nature.

[18]  Taylor J. Maxwell,et al.  DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. , 2006, Human molecular genetics.

[19]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[20]  D. Blacker,et al.  Assessment of Alzheimer’s disease case–control associations using family-based methods , 2009, neurogenetics.

[21]  A. Fagan,et al.  Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta , 2009, neurogenetics.

[22]  T. Hupp,et al.  DAPK-1 Binding to a Linear Peptide Motif in MAP1B Stimulates Autophagy and Membrane Blebbing* , 2008, Journal of Biological Chemistry.

[23]  S. DeKosky,et al.  No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease , 2009, Neurobiology of Aging.

[24]  D. Avramopoulos.  Genetics of Alzheimer's disease: recent advances , 2009, Genome Medicine.

[25]  L. Tan,et al.  Single nucleotide polymorphism rs1333049 on chromosome 9p21.3 is associated with Alzheimer's disease in Han Chinese. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[26]  L. Tan,et al.  Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[27]  L. Tan,et al.  Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease , 2010, Brain Research.

[28]  A. Cuervo,et al.  Autophagy gone awry in neurodegenerative diseases , 2010, Nature Neuroscience.

[29]  J. Lowe,et al.  Death‐associated protein kinase (DAPK1) in cerebral cortex of late‐onset Alzheimer's disease patients and aged controls , 2010, Neuropathology and applied neurobiology.